SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-037754
Filing Date
2024-09-23
Accepted
2024-09-23 07:00:32
Documents
17
Period of Report
2024-09-20
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53872
2 ex3-1.htm EX-3.1 875
3 ex3-1_001.jpg GRAPHIC 595936
4 ex99-1.htm EX-99.1 15800
5 ex99-1_001.jpg GRAPHIC 15098
  Complete submission text file 0001493152-24-037754.txt   1097041

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE orgs-20240920.xsd EX-101.SCH 3018
7 XBRL LABEL FILE orgs-20240920_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE orgs-20240920_pre.xml EX-101.PRE 24167
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3652
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 241314610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)